BlackRock »

Tonix Pharmaceuticals Hldg C shares owned by BlackRock

Quarter-by-quarter ownership of Tonix Pharmaceuticals Hldg C (TNXP) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Tonix Pharmaceuticals Hldg C

Tip: Access up to 7 years of quarterly data

All positions including Tonix Pharmaceuticals Hldg C held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tonix Pharmaceuticals Hldg C by BlackRock

Quarter filed Position value Share count Share price at filing
2024-09-30 $0 791 0.00

More positions owned by BlackRock

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
UnitedHealth (UNH)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Visa Com Cl A (V)

View all positions for BlackRock

Top funds holding Tonix Pharmaceuticals Hldg C

Virtu Financial
Geode Capital Management
Wedbush Morgan Securities
LPL Financial
Jane Street
Vanguard Group
JustInvest
Jump Financial
MRP Capital Investments
Tower Research Capital
BlackRock
BlackRock
Capital Advisors
Qube Research & Technologies
Morgan Stanley

View all funds holding Tonix Pharmaceuticals Hldg C